BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lovastatin
,
rs6983267
,
PPARA
,
Apoptosis
,
Breast Cancer
,
Endothelial cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cbfb protein
Summary
General Info
Curated Studies
Most Correlated Studies
Splenic gene expression in AML mice expressing full length and truncated CBFb-SMMHC fusion protein
Leukemia fusion-gene transduced human cord blood cells
Cbfb-deficient regulatory T cells in mice
Peripheral blood from CBFβ-SMMHC fusion knock-in mice with truncated CBFβ
Mononuclear cells from acute myeloid leukemia with core binding factor rearrangements
Explore Curated Studies Results
Literature
Most Relevant Literature
Autophagy Inhibition as a Potential Therapeutic Strategy for Breast Cancer with Mitochondrial Transl…
Bundles of Auer rods in mature neutrophils in an acute myeloid leukaemia patient with inv(16)(p13.1q…
Heterozygous pathogenic variants involving CBFB cause a new skeletal disorder resembling cleidocrani…
Bundles of Auer rods in maturing myeloid cells in a case of acute myeloid leukaemia with CBFB::MYH11…
CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
BL-8040 Addition to Consolidation Therapy in AML Patients
Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia i…
Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ